vcn-01,durvalumab
synthetic biologics,astrazeneca
['vcn-01', 'durva']
safety+pk+tumor/blood pd data from of vcn-01 (oncolytic virus developed in-house ) in combination with durvalumab for r/m hnscc! with check it out #esmo22 #oncoalert 
Medical Oncologist. Head and Neck Cancer and Early Drug Development. Currently at Catalan Institute of Oncology. Former PMH DDP Fellow. Opinions are my own.